ReviewFrontiers in neuroscience2026
The tubulin code in acute ischemic stroke: post-translational reprogramming of the neuronal cytoskeleton and implications for phase-specific neuroprotection.
Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute ischemic stroke initiates a rapid convergence of excitotoxicity, calcium overload, oxidative stress, neuroinflammation, and energetic failure. Although reperfusion therapies remain central to acute care, they do not directly address the structural failure of injured neuronal networks. This narrative review examines the neuronal microtubule cytoskeleton as an active regulatory platform whose function is governed by the tubulin code: tubulin isotype composition and post-translational modifications. The review integrates evidence that ischemia alters alpha-tubulin K40 acetylation, detyrosination, delta-2 tubulin accumulation, and polyglutamylation, while also examining emerging roles for palmitoylation, lactylation, and glycylation-related PTM cross-talk. Particular emphasis is placed on the HDAC6-alpha-tubulin acetylation axis, MIF-AIF parthanatos signaling, vasohibin-dependent detyrosination, CCP1-dependent control of polyglutamylation, TUBA4A-GSK3beta-Tau scaffolding, beta-tubulin isotype effects on whole-lattice behavior, and lactylation-mediated repair. Together, these pathways support a phase-specific model in which early cytoprotection preserves transport-competent microtubules, whereas later recovery requires adaptive cytoskeletal remodeling and neuroplasticity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.